Overview
Cystic echinococcosis (CE) is a parasitic disease caused by the larval stage of Echinococcus species, primarily E. granulosus and E. multilocularis, leading to cyst formation in various organs, most commonly the liver and lungs 1.Diagnosis
Imaging studies (CT, MRI) are essential for detecting and assessing the size, location, and characteristics of echinococcial cysts 1.
Serological tests (ELISA, indirect hemagglutination assay) help confirm the diagnosis but may show false positives or negatives 1.
Histopathological examination of cyst fluid or tissue samples provides definitive diagnosis 1.Management
Surgical intervention: Recommended for large cysts, cysts causing significant compression symptoms, or suspected rupture 1.
Albendazole: First-line medical treatment, typically dosed at 15 mg/kg/day for 8-12 weeks preoperatively and continued for 1-4 weeks postoperatively 1.
Mebendazole: An alternative to albendazole, though less commonly used 1.
Monitoring: Regular imaging follow-ups to assess cyst evolution and treatment response 1.Special Populations
Pregnancy: Management strategies should balance maternal and fetal safety; surgical intervention may be prioritized over pharmacological treatment due to drug safety concerns 1.
Pediatrics: Tailored treatment approaches considering growth and developmental impacts; close monitoring is crucial 1.
Elderly and comorbidities: Treatment plans should consider overall health status and potential complications; conservative management may be favored in high-risk patients 1.Key Recommendations
Use imaging studies (CT, MRI) for diagnosis and monitoring of cystic echinococcosis 1.
Employ albendazole as first-line medical therapy at 15 mg/kg/day for 8-12 weeks preoperatively and continue for 1-4 weeks postoperatively 1 (Evidence: Strong).
Prioritize surgical intervention for large cysts, symptomatic cases, or suspected rupture 1 (Evidence: Moderate).
Tailor management in special populations like pregnant women, children, and elderly patients considering their specific health needs 1 (Evidence: Expert opinion).References
1 Belhassen-Garcia M, Balboa Arregui Ó, Calabuig-Muñoz E, Carmena D, Esteban Velasco MDC, Fuentes Gago M et al.. Executive Summary of the Consensus Statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Tropical Medicine and International Health (SEMTSI), the Spanish Association of Surgeons (AEC), the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), the Spanish Society of Thoracic Surgery (SECT), the Spanish Society of Vascular and Interventional Radiology (SERVEI), and the Spanish Society of Paediatric Infectious Diseases (SEIP), on the Management of Cystic Echinococcosis. Enfermedades infecciosas y microbiologia clinica (English ed.) 2020. link
2 Matulionytė R, Lisauskienė I, Kėkštas G, Ambrozaitis A. Two dog-related infections leading to death: overwhelming Capnocytophaga canimorsus sepsis in a patient with cystic echinococcosis. Medicina (Kaunas, Lithuania) 2012. link